IP Library Granted Patent US 11,679,086
Granted Patent B2
US 11,679,086 · App. 17/200,481 · Granted Jun 20, 2023

Systems comprising a composite backing and methods for long term transdermal administration

Inventors: Eun Soo Lee (Redwood City, CA); Amit K. Jain (Milpitas, CA); Parminder Singh (Union City, CA)
Assignee: Corium, LLC
A61K9/7084A61K9/0014A61K9/7053A61K9/7061A61K9/7069A61K41/00A61K47/34A61M35/00A61K9/703
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,679,086
App. No.
17/200,481
Granted
Jun 20, 2023
Kind
B2
Abstract

Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.

Claims (29)

1. A method for treating Alzheimer's disease, comprising:

providing a transdermal patch comprised of

a composite backing layer comprised of (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised of one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films; wherein the first and second layers are in contact and the second and third layers are in contact, and wherein the third layer comprises cuts formed at least partially through the layer; and

an adhesive matrix drug layer laminated to the third layer, the adhesive matrix drug layer comprising a drug.

2. The method of claim 1 , further comprising instructing to apply the transdermal patch to skin for delivery of the drug.

3. The method of claim 1 , wherein the polymer fabric or polymer film of the first layer is comprised of one or more polymers selected from polyesters, polyethylenes, polypropylenes, polyvinylchloride, polyethylene vinyl acetate or copolymers thereof, and polyurethanes.

4. The method of claim 1 , wherein the first layer is selected from a woven polymer fabric, a non-woven polymer fabric, a polymer laminate, and a polymer/metal laminate.

5. The method of claim 1 , wherein the first layer has a thickness of about 0.5-10 mil.

6. The method of claim 1 , wherein one or more of the polymers of the second layer has at least one of (i) a tensile strength of less than 10 MPa and (ii) an elongation of at least 50%.

7. The method of claim 1 , wherein the one or more adhesive polymers of the second layer are selected from acrylates, acrylate copolymers, polyisobutylene, silicone, polystyrene butyl rubber, polyethylene vinyl acetate and copolymers thereof, and plasticized polymers.

8. The method of claim 1 , wherein the second layer has a thickness of about 0.5-30 mil.

9. The method of claim 1 , wherein the third layer has a thickness of about 1-40 mil.

10. The method of claim 1 , wherein the drug is donepezil.

11. The method of claim 1 , wherein the first layer, second layer, and third layer are laminated.

12. The method of claim 1 , wherein the third layer is a laminate of two polymer films.

13. A method for delivery of donepezil through skin, comprising:

providing a transdermal patch comprised of a composite backing layer comprising (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films, wherein the third layer comprises cuts formed at least partially through the layer; wherein the first layer, second layer, and third layers are arranged in contact as a composite; (iv) an adhesive drug layer comprising donepezil, the adhesive drug layer laminated to the third layer; and (v) a release liner;

wherein donepezil is delivered through skin upon removal of the release liner and application of the transdermal patch to skin.

14. The method of claim 13 , wherein the first layer polymer fabric or polymer film is comprised of one or more polymers selected from polyesters, polyethylenes, polypropylenes, polyvinylchloride, polyethylene vinyl acetate or copolymers thereof, and polyurethanes.

15. The method of claim 13 , wherein the first layer is selected from an occlusive polymer film, a polymer laminate, a polymer/metal laminate, a breathable polymer film, a woven polymer fabric and a non-woven polymer fabric.

16. The method of claim 13 , wherein the first layer has a thickness of about 0.5-10 mil.

17. The method of claim 13 , wherein the one or more polymers of the second layer are selected from acrylates, acrylate copolymers, polyisobutylene, silicone, polystyrene butyl rubber, polyethylene vinyl acetate and copolymers thereof, and plasticized polymers.

18. The method of claim 13 , wherein the second layer has a thickness of about 0.5-30 mil.

19. The method of claim 13 , wherein the third layer has a thickness of about 1-40 mil.

20. The method of claim 13 , wherein the release liner is formed of a material selected from a silicone coated polyethylene terephthalate, a fluorocarbon, a fluorocarbon coated polyethylene terephthalate, and a fluorosilicone coated polyethylene terephthalate.

21. A method for treating Alzheimer's disease in a subject, comprising:

applying a transdermal patch to skin of the subject, wherein the transdermal patch comprises

a composite backing layer comprised of (i) a first layer comprised of a polymer fabric or a polymer film having a stretchability of at least 5% in at least one direction; (ii) a second layer comprised of one or more adhesive polymers; and (iii) a third layer comprised of one or more polymer films; wherein the first and second layers are in contact and the second and third layers are in contact, and wherein the third layer comprises cuts formed at least partially through the layer; and

an adhesive matrix drug layer laminated to the third layer, the adhesive matrix drug layer comprising a drug.

Assignments (5)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 19, 2024
From: CORIUM, LLC
To: COLUMBUS INVESTMENT HOLDINGS SA
Reel/Frame 066355/0628 →
CHANGE OF NAME Recorded Oct 25, 2022
From: CORIUM, INC.
To: CORIUM, LLC
Reel/Frame 061852/0142 →
SECURITY INTEREST Recorded Sep 24, 2021
From: CORIUM, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 057597/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: LEE, EUN SOO; JAIN, AMIT K.; SINGH, PARMINDER
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 056843/0899 →
CHANGE OF NAME Recorded Jul 13, 2021
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 056861/0609 →